Clostridium Difficile Infection: Clinical Trials

7 trials for Clostridium Difficile Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 7

Follow Clostridium Difficile Infection: new trials by email Literature Review of Clostridium Difficile Infection trials Research Report on Clostridium Difficile Infection

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fecal Microbiota Transplant
Fecal Microbiota Transplant - Clostridium Difficile Infection
Phase 4CompletedMethodist Health System242018-06-052026-03-24
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
Oral Vancomycin - Clostridium Difficile Infection
Phase 4CompletedUniversity of Nevada, Reno1042018-03-082023-11-28
TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment
Oral Vancomycin, Placebo, Toxin enzyme immunoassay - Clostridium Difficile Infection, Diarrhea
Phase 4CompletedWashington University School of Medicine152017-12-292021-07-26
Screening to Prophylax Against Clostridium Difficile Infection -
Vancomycin, Placebo - Clostridium Difficile Infection
Phase 4CompletedCorewell Health East12942016-12-192024-08-13
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
Vancomycin Oral - Clostridium Difficile Infection, Prophylaxis
Phase 4CompletedSt. Luke's Hospital, Chesterfield, Missouri512016-11-012017-12-27
Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea
Rifaximin, Placebo - Clostridium Difficile Infection
Phase 4CompletedUniversity of Nottingham1512012-12-012021-10-14
Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin
Vancomycin, Fidaxomicin - Clostridium Difficile Infection
Phase 4CompletedHartford Hospital342012-10-172017-06-28

Narrower conditions

Clostridium Infections (7)  ·  Diarrhea (2)

Broader conditions

Bacterial Infections (7)  ·  Bacterial Infections and Mycoses (7)  ·  Gram-Positive Bacterial Infections (7)  ·  Infections (7)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Signs and Symptoms, Digestive (2)

Interventions

Vancomycin (5)  ·  Fecal Microbiota Transplantation (1)  ·  Fidaxomicin (1)  ·  Rifaximin (1)

Sponsors

Corewell Health East (1)  ·  Hartford Hospital (1)  ·  Methodist Health System (1)  ·  St. Luke's Hospital, Chesterfield, Missouri (1)  ·  University of Nevada, Reno (1)  ·  University of Nottingham (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)  ·  United Kingdom (1)

Top investigators

Aida Jawhari, MD (1)  ·  Erik Dubberke, MD, MSPH (1)  ·  Lauren Zion, PharmD (1)  ·  Matthew Sims, MD PhD (1)  ·  Muhammad Memon, MD (1)  ·  Ryan E Medas, PharmD (1)

Results publications

PMID 26592763, PMID 27558181, PMID 30254135, PMID 33441409